SCHEMBL5784709

SCHEMBL5784709

CC(=O)C(C)(C)c1cnc[nH]1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP17A1 P05093 13/20 0.41
▸ CYP3A4 P08684 11/20 0.41
▸ CYP19A1 P11511 1/20 0.40
▸ QPCT Q16769 1/20 0.39
▸ QPCTL Q9NXS2 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.37
▸ GABRA1 P14867 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ GABRR1 P24046 1/20 0.37
▸ GABRR2 P28476 1/20 0.37
▸ GABRA5 P31644 1/20 0.37
▸ GABRB2 P47870 1/20 0.37
▸ GABRA4 P48169 1/20 0.37
▸ HRH4 Q9H3N8 1/20 0.37
▸ FKBP5 Q13451 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ PMP22 Q01453 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19630396 0.72 HRH4 (0.35) CYP17A1CYP3A4CYP19A1QPCTQPCTL
SCHEMBL12261150 0.71 HRH4 (0.39) CYP17A1CYP3A4CYP19A1ALDH1A1HRH4
SCHEMBL27617871 0.70 — —
Diketopiperazine SCHEMBL28290092 0.68 CYP17A1 (0.36) CYP17A1CYP3A4CYP19A1ALDH1A1HRH4
SCHEMBL21249866 0.67 ALDH1A1 (0.39) CYP17A1CYP3A4CYP19A1ALDH1A1HRH4
SCHEMBL27766969 0.65 TDP1 (0.38) CYP17A1CYP3A4CYP19A1ALDH1A1HRH4
SCHEMBL12629148 0.65 HRH4 (0.44) CYP17A1CYP3A4CYP19A1ALDH1A1HRH4
SCHEMBL8908834 0.65 TP53 (0.43) CYP3A4CYP19A1ALDH1A1GABRA1TSHR
SCHEMBL26068453 0.65 ALDH1A1 (0.43) CYP17A1CYP3A4CYP19A1ALDH1A1HRH4
SCHEMBL14415970 0.65 HRH4 (0.44) ALDH1A1TSHRHRH4FKBP5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1631566-A1 2-ANILINO-4-(IMIDAZOL-5-YL)-PYRIMIDINE DERIVATIVES AND THEIR USE AS CDK (CDK2) INHIBITORS Astrazeneca AB (SE) 2006-03-08 — — EP disclosed
WO-2004101549-A1 2-ANILINO-4-(IMIDAZOL-5-YL)-PYRIMIDINE DERIVATIVES AND THEIR USE AS CDK (CDK2) INHIBITORS ASTRAZENECA AB (SE) 2004-11-25 — — WO disclosed
Send feedback